Literature DB >> 7204113

[The indications for middle ear instillation of gentamicin in Menière's disease (author's transl)].

G Lange.   

Abstract

Menière's disease treated by use of Gentamicin sulphate instillation into the middle ear is reported. This drug is injected via a small plastic tube which is inserted into the middle ear. 4 mgm (0.1 ml) of Gentamicine sulphate are instilled every 5 hours until the labyrinth begins to show a reaction. After this treatment 95 per cent of patients no longer suffer from vertigo and tinnitus and the pressure feeling are favourably influenced. The hearing mainly remains unchanged, but sometimes may even improve.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204113

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  3 in total

1.  [Transtympanic administration of gentamicin in Menière diseases--less is more!?].

Authors:  A Koitschev
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

2.  Low-dose intratympanic gentamicin treatment of Menière's disease.

Authors:  H Inoue; Y Uchi; K Nogami; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

3.  Transtympanic administration of aminoglycosides in patients with Menière's disease.

Authors:  T Sala
Journal:  Arch Otorhinolaryngol       Date:  1988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.